Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers a survival benefit to adult patients affected by acute lymphoblastic leukemia (ALL). However, to avoid an overt disease relapse, patients with pre or post transplant persistence or occurrence of measurable residual disease (MRD) m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tecchio, Cristina, Russignan, Anna, Krampera, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992536/
https://www.ncbi.nlm.nih.gov/pubmed/36910638
http://dx.doi.org/10.3389/fonc.2023.1047554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992536/
https://www.ncbi.nlm.nih.gov/pubmed/36910638
http://dx.doi.org/10.3389/fonc.2023.1047554

Ejemplares similares